我们应该在稳定性缺血性心脏病中使用阿司匹林或P2Y抑制剂单疗法吗?
Rishi Chandiramani1, Adhya Mehta2, Roger S Blumenthal1
1, 600 N Wolfe St sted 560, Baltimore, MD, 21287, USA.
对于稳定的缺血性心脏病,克洛皮多格雷尔单一治疗显示出比阿司匹林更低的血栓和出血风险. 个性化风险评估指导双抗血小板治疗后未来抗血小板治疗的持续时间.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 阿司匹林一直是冠状动脉疾病二次预防的基石.
- 当代的药物侵入性策略促使人们重新评估阿司匹林的作用.
研究的目的:
- 审查目前关于阿司匹林或P2Y12抑制剂单疗在稳定缺血性心脏病的证据和指导方针.
- 探索个性化出血和血栓风险评估的未来方向.
主要方法:
- 审查最近的证据和指导方针建议.
- 对来自HOST-EXAM研究和PANTHER元分析的发现进行分析.
主要成果:
- 后检查:克洛皮多格雷尔单一治疗显示血栓和出血事件比阿司匹林低.
- PANTHER元分析:与阿司匹林相比,单独使用P2Y12抑制剂可以减少心肌梗塞,支架血栓,肠道出血和中风.
- 这两项研究都指出了类似的全因和心血管死亡率,以及主要出血率.
结论:
- 克洛皮多格雷尔单一治疗是阿司匹林的可行替代方案,用于稳定缺血性心脏病的二次预防.
- 在PCI后六个月的双重抗血小板治疗是标准的,但持续时间应该是个性化的.
- 未来的策略包括个性化风险评估,以定制抗血小板治疗.
更多相关视频
04:30A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
